Research center

Research center

The Institut Pasteur de Montevideo, inaugurated in December 2006, emerged as a result of an agreement between the University of the Republic, the Uruguayan government, and the Institut Pasteur Paris (France). As a result, it became one of the 33 member institutes within the International Network of Pasteur Institutes.

The Institut Pasteur de Montevideo was conceived as a private nonprofit foundation, a Uruguayan research center capable of adapting to the ongoing advances in science and technology. Its mission is to be a center of excellence in scientific research and to contribute to the country's development by providing technology to the productive sector, addressing the needs of our society.

The development of research infrastructure with cutting-edge technological platforms open to scientific users from both the country and the region has been a central focus from the beginning, alongside the promotion of high-quality scientific research and advanced training courses.

Research lines

With approximately 250 individuals, including researchers, graduate students, and administrative staff, the Institut Pasteur de Montevideo carries out its activities in a building spanning over 4000 square meters. Currently, the main research areas focus on neurodegenerative diseases, cancer, infectious diseases (virology, bacteriology, and parasitology), human genetics, cellular biology, and bioinformatics.

The technological platforms provide equipment and expertise in Proteomics and Analytical Protein Biochemistry, X-ray Crystallography, Recombinant Proteins and Protein Engineering, Advanced Bioimaging, Eukaryotic Cell Technology, Molecular Biology, Genomics and Bioinformatics, and Laboratory Animal Biotechnology.

Instrumentation

Let’s keep unlocking the power of collaboration 💪🔬@AdeliaBelem visited @NanotecLNNano supported by our Mobility Fellowships, where she met new colleagues and learned the entire cryomicroscopy routine, including single particle analysis and cryo-tomography 👇

This project has been made possible in part by a grant from the Chang Zuckerberg Initiative DAF, an advised fund of Silicon Valley.